Kanvas Biosciences Raises $12M in Pre-Series A
Summary
Kanvas Biosciences, a Monmouth Junction, NJ-based company which specializes in advancing microbiome mapping technology, raised $12M in Pre-Series A funding. As part of the investment round, Jason Pontin, partner at DCVC, will join the company’s board of directors. Leveraging its ability to spatially map the microbiome and profile host-gene expression at single-cell resolution, the company is constructing a comprehensive microbiome data resource for future drug development. The platform determines the identity and function of these microbes and maps the host’s corresponding local response – all executed within a single, comprehensive assay. It can be applied to the discovery and development of novel, live biotherapeutic products, the identification of disease-associated microbes for diagnostics, and leveraging the microbiome to improve therapeutic responses.